TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Neglect Anosognosia Score on Catherine Bergego Scale (CBS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall response rate by RECIST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Management of venous leg ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Adherence to evidence-based quality-of-care indicators
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pain intensity level measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional ability measurement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Knee ROM measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Tissue Oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with at Least One Clinical Laboratory Test Abnormality for Hematology Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Participants with at Least One Clinical Laboratory Test Abnormality for Blood Chemistry Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with at Least One Vital Sign Abnormality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with at Least One Abnormality on Electrocardiogram (ECG) Recordings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postoperative Shivering
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in calculated LDL-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Single leg Stance (SLS) Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wheal Response-time AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Maternal Participants with Solicited Local and Systemic Adverse Reactions (ARs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Maternal Participants with Unsolicited Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Maternal Participants with Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Interclinoid Distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sella Depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sella Diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sn^GoGn angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ArGo^GoGn angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of post-micturition dribble
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Insulin sensitivity index (HOMA-ISI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in mean Pulmonary Arterial Pressure (mPAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: surgical reinterventions
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Patients With Confirmed Delirium or Dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants Diagnosed With Dementia Among Those With Completed Outpatient Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neck Pain Rating Scale (NPRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life (SF-36 questionnaire)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Visual acuity (Snellen/logMAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Refractive error (automated refraction in diopters)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-operative refractive outcome in diopters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Level of Migraines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Overactive Bladder Questionnaire Long Form Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Geometric Mean Titer (GMT) of SARS-CoV-2-Specific Antibody at Day 29
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroresponse Rate of Vaccine Recipients at Day 29
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants with Solicited Local and Systemic Reactogenicity Adverse Reactions (ARs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percent weight loss at Month 12 - Topiramate vs placebo
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent weight loss at Month 12 - Phentermine vs placebo
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent weight loss at Month 12 - Phentermine/Topiramate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Progression free survival at 18 months
Endpoint domain: Mortality/survival
Primary endpoint: Change from baseline in Insulin-like Growth Factor 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change from baseline in Neurofilament light Chain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Frequency of COPD exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Prevalence of biochemical validated abstinence
Endpoint domain: Mortality/survival
Primary endpoint: Modified Lund-Kennedy (mLK) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of oral/topical corticosteroid utilization per participant
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants With Acute Procedural Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants With SAE Related to the Procedure or Device at 7 Days Post Index Procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Neurophysiological outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of Correct Answers on Antimicrobial Resistance Attitudes
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Social Behavior of ASD Children
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Mental Health of ASD Children
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: left ventricular dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of treatment emergent adverse events and serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Endogenous insulin secretion as assessed by 90-minute MMTT-stimulated C-peptide >0.5 ng/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Heart Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Occurrence status of infections
Endpoint domain: Adverse events/effects
Primary endpoint: Montgomery-Asberg Depression Ratings Scale (MADRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-Rated Inventory of Side Effects (PRISE)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in myocardial extracellular volume (MRI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in N-terminal pro b-type natriuretic peptide (NT-proBNP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in average E/e' ratio and tricuspid regurgitation velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in left atrial volume index (LAVi)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Speech Intelligibility
Endpoint domain: Life impact
Endpoint subdomain: Communication functioning
Primary endpoint: Therapy response in parathyroid carcinoma and atypical parathyroid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with plasma HIV-1 RNA ≥50 copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and intensity of treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Clinically significant changes in urine total glycosaminoglycan (GAG) concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and intensity of infusion-related reactions (IRRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Intention to quit smoking cigarillos in the next 30 days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hypersensitivity Assessment
Endpoint domain: Adverse events/effects
Primary endpoint: Concentration of progesterone over 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Percentage of Patients Experiencing Dose-Limiting Toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: TMS Evoked Potential amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Self-reported HIV or STI Testing in Past 3 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Receptive Condomless Anal Intercourse or Condomless Vaginal Intercourse in Past 3 Months
Endpoint domain: Adverse events/effects
Primary endpoint: Detection rate of druggable genetic alteration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative opioid morphine equivalent dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anticipated drainage of cerebrospinal fluid (CSF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of General Anesthesia for Cesarean Delivery
Endpoint domain: Surgical and medical procedures outcomes
Primary endpoint: Changes in lipid biomarker profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in immune biomarker profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants Who Have Regression at 6 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breastfeeding Duration 1
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Breastfeeding Duration 2
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Breastfeeding Exclusivity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: common carotid artery (CCA) flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Efficacy of Xanamem on attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short-term safety and tolerability of Xanamem
Endpoint domain: Adverse events/effects
Primary endpoint: Supersaturation of calcium oxalate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in the Number of Monthly Migraine Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Frequency of surgical complications after pancreatic surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Change in binge frequency (EDE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in binge frequency (EDE-Q)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of clinical malaria confirmed by RDT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in prevalence of microscopy-confirmed infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pre-post change in prevalence of PCR-confirmed infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Changes from Baseline in systolic and diastolic blood pressure (BP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes from Baseline in heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite of New Onset Major Adverse Events (MAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of post-operative hypocalcemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Difference in Adenomas Per Colonoscopy (APC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Difference in Positive Percent Agreement (PPA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preterm Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preterm Crying
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthy Kids childhood obesity risk score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving 55% reduction in IHS4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of disease progression preceded by BRCA1/2 reversion mutation detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Annualized rate of asthma exacerbation events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: acceptance of a digital remote monitoring solution
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: usability of a digital remote monitoring solution
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Participants With Treatment-emergent Laboratory Abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Persistence to antifibrotic treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage change in urinary protein-creatinine ratio (UPCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Changes in estimated glomerular filtration rate (eGFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage change in urinary albumin-creatinine ratio (UACR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Changes of HbA1c level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes of CAP score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Composite Adverse Endpoint (CAE)
Endpoint domain: Adverse events/effects
Primary endpoint: fraction of [¹⁴C]-radioactivity excreted in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fraction of [¹⁴C]-radioactivity excreted in faeces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve of the analyte in plasma for [¹⁴C]-BI 907828
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve of the analyte in plasma for BI 907828
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Dose Limiting Toxicity (DLT) events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with symptomatic hypocalcemia
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with symptomatic hypercalcemia
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with symptomatic citrate accumulation
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in headache attack days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUROC of convolutional neural network in predicting OBL area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUROC of convolutional neural network in predicting progressive suction loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUROC of convolutional neural network in predicting effective optical zone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall coagulation activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of Relapse-Free Participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to First Relapse (TFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in continuous glucose monitor (CGM) time-in-range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cancer related self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of Major Pathological Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound infection evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incision cosmetic result at 2 months post-op
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incision cosmetic result at 6 months post-op
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of F/TAF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct prediction of embryo ploidy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wisconsin Upper Respiratory Symptom Survey (WURSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in IL-8 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: MRD conversion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Participants Achieving Disease Remission at Week 26
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Participants With Sustained Disease Remission at Week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of catheter-related infections
Endpoint domain: Adverse events/effects
Primary endpoint: Intention to engage in reducing exposure
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Intention to undertake decontamination behaviour
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Time to local failure
Endpoint domain: Mortality/survival
Primary endpoint: Change in Prothrombin Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Position of vocal cords
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Movement of vocal cords
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of newborn screened
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change of request for pharmacological analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived Stress Scale for Nursing Students
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PSQI Scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Percent change in EEG amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percent change in EEG frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Isometric Hip Abductor Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: At least 75% reduction in Eczema Area and Severity Index (EASI) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of retrieved COCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in serum leptin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in serum irisin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in ADHD Combined Type Symptom Severity Score (Parent Checklist)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ADHD Combined Type Symptom Severity Score (Teacher Checklist)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ODD Symptom Severity Score (Parent Checklist)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ODD Symptom Severity Score (Teacher Checklist)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Overall Severity Score (IRS Parent Questionnaire)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Overall Severity Score (IRS Teacher Questionnaire)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes